We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MiMedx Group Inc | NASDAQ:MDXG | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.16 | 2.24% | 7.29 | 7.27 | 7.33 | 7.425 | 7.13 | 7.13 | 708,104 | 21:00:02 |
A pre-recorded presentation will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com beginning on November 25, 2020 at 5:00 PM Eastern Time and will be accessible for approximately 45 days.
About MiMedxMiMedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.
ContactHilary DixonInvestor Relations & Corporate Communications770.651.9066investorrelations@mimedx.com
1 Year MiMedx Chart |
1 Month MiMedx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions